Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Titel:
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial
Auteur:
Khalaf, Daniel J Annala, Matti Taavitsainen, Sinja Finch, Daygen L Oja, Conrad Vergidis, Joanna Zulfiqar, Muhammad Sunderland, Katherine Azad, Arun A Kollmannsberger, Christian K Eigl, Bernhard J Noonan, Krista Wadhwa, Deepa Attwell, Andrew Keith, Bruce Ellard, Susan L Le, Lyly Gleave, Martin E Wyatt, Alexander W Chi, Kim N